Free Newsletter
France to probe GSK, Sanofi vaccination campaign
French authorities are investigating GlaxoSmithKline and Sanofi Pasteur over an anti-hepatitis B vaccination campaign in the 1990s. At issue is whether the companies fully disclosed the shot's potential side effects.
The probe also includes accusations of manslaughter against Sanofi Pasteur MSD, a joint venture of Sanofi Aventis and Merck. The allegations stem from the death of a young woman from multiple sclerosis; the woman had been vaccinated. A Sanofi official called the charges "unjustified," saying that 11 studies have shown no link between the hepatitis B vaccine and MS.
The vaccination campaign in question ran from 1994 to 1998, but then was suspended because of concerns about possible side effects. Thirty plaintiffs have filed civil claims, including the families of five who died after being vaccinated.
- read the story at CNN Money
- read more background at Pharmalot
Related Article:
France picks Gardasil over GSK upstart. Report
Comments
Post new comment
Paid Research Reports
- The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
- New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency
- Stakeholder Opinions: Vaccine antigen delivery technologies - Molecular systems to open new markets
- The Top 10 Contract Research Organizations
- Stakeholder Opinions: Vaccine administration technologies - Beyond needles
- Future Pharmaceutical Industry Trends: Long-term opportunities tempered by short-term challenges





Click here to get the FierceVaccines email newsletter for FREE!
Be the first to comment